[Neutral and acid glycolipids in the brain in the presence of ischemia and during antioxidant treatment].
The content of lipid peroxidation products and the metabolism of gangliosides and galactosylceramides in brain tissue were studied in the presence of ischemia and when an agent containing nicotinic acid and cysteine is administered. The above agent was found to have an antioxidative effect that was evident in the lower levels of lipid peroxides and in the normalized qualitative and quantitative content of galactosylceramides and gangliosides.
L M
LM
Ovsepian
G V
GV
Zakharian
M M
MM
Melkonian
A V
AV
Zakharian
M A
MA
aganiants
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D001923:Brain Chemistry / Q000187:drug effects; D002545:Brain Ischemia / Q000188:drug therapy* / Q000378:metabolism*; D003545:Cysteine / Q000494:pharmacology*; D006017:Glycolipids / Q000378:metabolism*; D015227:Lipid Peroxidation / Q000187:drug effects*; D008297:Male; D009525:Niacin / Q000494:pharmacology*; D051381:Rats; D014803:Vitamin B Complex / Q000494:pharmacology
D000975:Antioxidants; D006017:Glycolipids; D014803:Vitamin B Complex; D009525:Niacin; D003545:Cysteine